BRIEF-Intellipharmaceutics reports Q1 loss per share $0.09

Fri Apr 15, 2016 8:49am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 15 (Reuters) - Intellipharmaceutics International Inc

* Intellipharmaceutics announces first quarter 2016 results

* Q1 loss per share $0.09

* Q1 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S

* Plan to file new drug application for rexista oxycodone xr within three months on basis that no phase iii studies required

* Progress on rexista oxycodone xr continues, nda user fee waiver request filed Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)